USPTO trademark

EMNUVAQ

Under examinationUSPTOWord markClass 5

"EMNUVAQ" is a word mark owned by Sanofi R&D Vaccins, filed at the USPTO on April 1, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Sanofi R&D Vaccins portfolioGet this data via the API
Official USPTO record
EMNUVAQ trademark as filed
As filed with the USPTO
Status
Under examination
Since October 8, 2026
Filed
April 1, 2026
Registered
Not yet
Priority date
October 24, 2025
Claimed from France
Application no.
99737665
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns EMNUVAQ

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Sanofi R&D Vaccins

Lyon, France

94 trademarks in the portfolioView company

Representative

Alexandra Kochian

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services EMNUVAQ is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in immunology; Antibodies for medical purposes; Pharmaceutical preparations for the treatment and prevention of respiratory and inflammatory diseases and disorders; Vaccines for human use

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas/email correspondence entered
  2. Correspondence received in law office
  3. Assigned to lie
  4. Teas response to suspension inquiry received
  5. Notification of letter of suspension e-mailed
  6. Letter of suspension e-mailed
  7. Suspension letter written
  8. Assigned to examiner
  9. Application filing receipt mailed
  10. New application office supplied data entered

1 earlier step on the official record.

FAQ

About EMNUVAQ

Who owns the trademark "EMNUVAQ"?

The USPTO trademark "EMNUVAQ" (application 99737665) is owned by Sanofi R&D Vaccins.

What is the status of "EMNUVAQ"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull EMNUVAQ and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d5617-741f-725c-ad46-903cbbeda894
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d5617-741f-725c-ad46-903cbbeda894",
  "object": "trademark",
  "mark_text": "EMNUVAQ",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99737665",
  "filing_date": "2026-04-01",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Sanofi R&D Vaccins",
      "entity_id": "ent_019ebc31-6646-70f8-af06-ffa9d9c1e2f3"
    }
  ]
}